Characterization of Conjugated Protease Inhibitors

Total Page:16

File Type:pdf, Size:1020Kb

Characterization of Conjugated Protease Inhibitors Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1888 Characterization of conjugated protease inhibitors ERIKA BILLINGER ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6214 ISBN 978-91-513-0835-7 UPPSALA urn:nbn:se:uu:diva-398909 2020 Dissertation presented at Uppsala University to be publicly examined in B42, BMC, Husargatan, Uppsala, Thursday, 13 February 2020 at 09:15 for the degree of Doctor of Philosophy. The examination will be conducted in English. Faculty examiner: Professor Boris Turk (Jozef Stefan Institute, Department of Biochemistry, Molecular and Structural Biology). Abstract Billinger, E. 2020. Characterization of conjugated protease inhibitors. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 1888. 86 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-0835-7. The overall theme of this thesis is a step by step approach for the design and characterization of conjugated protease inhibitors. This involves both a new assay method for protease activity and protease inhibition (paper I), a study of the stoichiometry for protease inhibitor interaction (paper II), design of inhibitory peptides (paper IV) and the construction of inhibitor conjugates (paper III & IV). (I) A model based primarily on erosion in gelatin for protease activity and inhibition studies was designed. The model was also extended to a separate protective layer covering the layer containing the target substrate. A good correlation between protease concentration and rate of erosion was observed. Similarly, increased concentration of inhibitors gave a systematic decrease in the erosion rate. Kinetic analyses of a two-layer model with substrate in the bottom layer displayed a strict dependence of both inhibitor concentration and thickness of the top “protective” layer. (II) The binding stoichiometry between pancreatic proteases and a serine protease inhibitor purified from potato tubers was determined by chromatography-coupled light scattering measurements. This revealed that the inhibitor was able to bind trypsin in a 2:1 complex, whereas the data for a-chymotrypsin clearly showed a limitation to 1:1 complex. The same experiment carried out with elastase and the potato inhibitor gave only weak indications of complex formation under the conditions used. (III) A serine protease inhibitor was extracted from potato tubers and conjugated to soluble, prefractionated dextran or inorganic particles. A certain degree of inhibitory activity was retained for both the dextran-conjugated and particle-conjugated inhibitor. The apparent Ki value of the dextran-conjugated inhibitor was found to be in the same range as that for free inhibitor. The dextran conjugate retained a higher activity than the free inhibitor after 1 month of storage at room temperature. Conjugation to oxide particles improved the heat stability of the inhibitor. (IV) New synthetic Leupeptin analogues, Ahx-Phe-Leu-Arg-COOH & Ahx-Leu-Leu-Arg- COOH, were synthesized with solid-phase peptide synthesis using Fmoc strategy. These tripeptide inhibitors were tight binding inhibitors to the target enzyme trypsin, similar to the natural occurring leupeptin. The phenylalanine containing synthetic analogue was conjugated to inorganic particles and agarose gel beads. In all cases, the inhibitory activity was well preserved. Keywords: Serine protease inhibitors, conjugation, immobilization, leupeptin analogues, potato serine protease inhibitor, soluble carriers, inorganic carriers. Erika Billinger, Department of Chemistry - BMC, Box 576, Uppsala University, SE-75123 Uppsala, Sweden. © Erika Billinger 2020 ISSN 1651-6214 ISBN 978-91-513-0835-7 urn:nbn:se:uu:diva-398909 (http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-398909) Education is not the learning of facts, but the training of the mind to think - Einstein LIST OF PAPERS This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I Billinger, E., Johansson, G. Kinetic studies of serine protease in- hibitors in simple and rapid ‘active barrier’ model systems: Dif- fusion through an inhibitor barrier. Analytical Biochemistry, 2018, 546, 43–49. II Billinger, E., Zuo, S., Lundmark, K., Johansson, G. Light scat- tering determination of the stoichiometry for protease-potato ser- ine protease inhibitor complexes. Analytical Biochemistry, 2019, 582, 113357. DOI: 10.1016/j.ab.2019.113357 III Billinger, E.*, Zuo, S., Johansson G. Characterization of serine protease inhibitor from Solanum tuberosum conjugated to solu- ble dextran & particle carriers. ACS Omega, 2019, 4, 18456- 18464. DOI: 10.1021/acsomega.9b02815 *Corresponding author. IV Billinger, E., Viljanen, J., Bergström Lind, S., Johansson, G. In- hibition properties of free and conjugated leupeptin analogues. 2019. Submitted. Reprints were made with permission from the respective publishers. Further permissions related to paper III excerpted should be directed to the ACS. Publications not included in this thesis. V Kjellander, M., † Billinger, E., † Ramachandraiah, H., Boman, M., Bergström Lind, S., Johansson, G. A flow-through nanoporous alumina trypsin bioreactor for mass spectrometry peptide finger- printing. Journal of Proteomics, 2018, 172, 165-172. † These authors contributed equally. CONTRIBUTION REPORT I. Participated in formulating the research idea, planned and per- formed all experimental work, wrote the initial draft of the manu- script and shared the writing of the manuscript. II. Planned the overall experimental work, performed parts of it, par- ticipated in writing the manuscript. III. Participated in formulating the research idea, planned the initial scope, performed most experimental procedures, wrote a draft of the manuscript and organized the writing of the manuscript. Served as corresponding author. IV. Participated in formulating the research idea, planned and per- formed most experimental work, wrote the initial draft of the man- uscript and shared the writing of the manuscript. CONTENTS INTRODUCTION .....................................................................................11 ENZYMES ...........................................................................................12 Proteases ..........................................................................................14 The catalytic site ...............................................................................16 Recognition sites for the substrate .....................................................17 Kinetics of serine protease reaction ...................................................17 Inhibition ..........................................................................................21 SERINE PROTEASE INHIBITORS .....................................................25 Potato serine protease inhibitor .........................................................25 Peptide aldehydes .............................................................................26 CONJUGATION ..................................................................................29 Amide formation ..............................................................................31 Reductive amination .........................................................................32 Carriers ............................................................................................34 TOOLS SECTION ................................................................................39 Static light scattering (SLS) ..............................................................40 Solid-phase peptide synthesis (SPPS) ................................................43 Mass spectroscopy (MS) ...................................................................46 MY WORK ...............................................................................................49 PAPER I ...............................................................................................50 Kinetic studies of serine protease inhibitors in simple and rapid ‘active barrier’ model systems ..........................................................50 One-layer model ...............................................................................50 Two-layer model ..............................................................................52 Conclusions ......................................................................................53 PAPER II ..............................................................................................54 Light scattering determination of the stoichiometry for protease- potato serine protease inhibitor complexes .......................................54 The active sites .................................................................................54 Trypsin-PSPI interaction ...................................................................56 α-chymotrypsin-PSPI interaction ......................................................57 Elastase-PSPI interaction ..................................................................58 Conclusions ......................................................................................59 PAPER III.............................................................................................60 Characterization of serine protease inhibitor from solanum tuberosum conjugated to soluble dextran and particle carriers .........60 Prefractionation & oxidation of dextran ............................................60 Conjugation of PSPI .........................................................................61
Recommended publications
  • Plant Protease Inhibitors: a Defense Strategy in Plants
    Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1.
    [Show full text]
  • Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine. Uptake by Peptide Carrier Systems and Hydrolysis by Peptide Hydrolases
    Evidence for two different modes of tripeptide disappearance in human intestine. Uptake by peptide carrier systems and hydrolysis by peptide hydrolases. S A Adibi, … , S S Masilamani, P M Amin J Clin Invest. 1975;56(6):1355-1363. https://doi.org/10.1172/JCI108215. Research Article The intestinal fate of two tripeptides (triglycine and trileucine), which differ markedly in solubility and molecular weight, have been investigated by jejunal perfusion in healthy human volunteers. Rates of glycine or leucine uptake from test solutions containing triglycine or trileucine were greater than from test solutions containing corresponding amounts of free glycine or free leucine, respectively. The rate of glycine uptake from a 100 mM triglycine solution was greater than that from a 150 mM diglycine solution. At each infused load of triglycine (e.g., 1,000 mumol/min) the rates (micromoles/minutes per 30 cm) of either triglycine disappearance (810 +/- 40) or glycine absorption (2,208 +/- 122) were markedly greater than the luminal accumulation rates of either diglycine (56 +/- 10) or free glycine (110 +/- 18). The luminal accumulation rate of free leucine during infusion of a 5 mM trileucine solution was over threefold greater than that of free glycine during the infusion of a 5 mM triglycine solution. Luminal fluid exhibited no hydrolytic activity against triglycine, but contained some activity against trileucine. Saturation of free amino acid carrier system with a large load of leucine did not affect glycine absorption rate from a triglycine test solution, but isoleucine markedly inhibited the uptake from a trileucine solution. When the carrier system for dipeptides was saturated with a large amount of glycylleucine, […] Find the latest version: https://jci.me/108215/pdf Evidence for Two Different Modes of Tripeptide Disappearance in Human Intestine UPTAKE BY PEPTIDE CARRIER SYSTEMS AND HYDROLYSIS BY PEPTIDE HYDROLASES SIAMAK A.
    [Show full text]
  • Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides As Used in Cosmetics
    Safety Assessment of Tripeptide-1, Hexapeptide-12, and Related Amides as Used in Cosmetics Status: Draft Report for Panel Review Release Date: February 21, 2014 Panel Meeting Date: March 17-18, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1620 L STREET, N.W., SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: February 21, 2014 Subject: Draft Report on Tripeptide-1, Hexapeptide-12, and Related Amides The draft report on palmitoyl oligopeptides was tabled at the March 18-19, 2013 CIR Expert Panel meeting, pending reorganization of the safety assessment. During the meeting, the Panel was provided with a letter from the CIR Science and Support Committee, recommending the creation of a new ingredient group consisting of ingredients for which the peptide sequence is known, namely, tripeptide -1, hexapeptide-12 and specific related amides. This has been done. Additionally, at the March meeting, further information was sought to better understand the extent and manner in which solid-phase peptide synthesis is used to create the peptide portion of ingredients included in the safety assessment.
    [Show full text]
  • TRH-Like Peptides
    Physiol. Res. 60: 207-215, 2011 https://doi.org/10.33549/physiolres.932075 REVIEW TRH-Like Peptides R. BÍLEK1, M. BIČÍKOVÁ1, L. ŠAFAŘÍK2 1Institute of Endocrinology, Prague, Czech Republic, 2Urology Clinic, Beroun, Czech Republic Received September 6, 2010 Accepted October 8, 2010 On-line November 29, 2010 Summary of the leaders working in the area concerning the TRH TRH-like peptides are characterized by substitution of basic research was Professor V. Schreiber from Prague, Czech amino acid histidine (related to authentic TRH) with neutral or Republic, which already in 1959 formulated the acidic amino acid, like glutamic acid, phenylalanine, glutamine, hypothesis that adenohypophyseal acid phosphatase is tyrosine, leucin, valin, aspartic acid and asparagine. The related to thyrotropin secretion and that TRH is its presence of extrahypothalamic TRH-like peptides was reported in possible activator (Schreiber and Kmentova 1959, peripheral tissues including gastrointestinal tract, placenta, neural Schreiber et al. 1962). TRH precursor, human prepro- tissues, male reproductive system and certain endocrine tissues. TRH, consists of 242 amino acid residues, and contains Work deals with the biological function of TRH-like peptides in six separate copies of the TRH progenitor sequence different parts of organisms where various mechanisms may (Satoh and Mori 1994), which determine the primary serve for realisation of biological function of TRH-like peptides as structure of TRH as a tripeptide pyroglutamyl-histidinyl- negative feedback to the pituitary exerted by the TRH-like proline amide. The transcriptional unit of prepro-TRH is peptides, the role of pEEPam such as fertilization-promoting localized on chromosome 3 in humans (three exons peptide, the mechanism influencing the proliferative ability of interrupted by two introns) (Yamada et al.
    [Show full text]
  • Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption
    life Article Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption Santos Galvez-Martinez and Eva Mateo-Marti * Centro de Astrobiología (CSIC-INTA), Ctra. Ajalvir, Km. 4, 28850 Torrejón de Ardoz, Spain; [email protected] * Correspondence: [email protected]; Tel.: + 34-915-872-973 Received: 27 July 2018; Accepted: 9 October 2018; Published: 25 October 2018 Abstract: We characterized the adsorption of triglycine molecules on a pyrite surface under several simulated environmental conditions by X-ray photoemission spectroscopy. The triglycine molecular adsorption on a pyrite surface under vacuum conditions (absence of oxygen) shows the presence of + two different states for the amine functional group (NH2 and NH3 ), therefore two chemical species (anionic and zwitterionic). On the other hand, molecular adsorption from a solution discriminates the NH2 as a unique molecular adsorption form, however, the amount adsorbed in this case is higher than under vacuum conditions. Furthermore, molecular adsorption on the mineral surface is even favored if the pyrite surface has been irradiated before the molecular adsorption occurs. Pyrite surface chemistry is highly sensitive to the chemical changes induced by UV irradiation, as XPS analysis shows the presence of Fe2O3 and Fe2SO4—like environments on the surface. Surface chemical changes induced by UV help to increase the probability of adsorption of molecular species and their subsequent concentration on the pyrite surface. Keywords: pyrite; triglycine; XPS; peptide; sulfide mineral; UV; surface; adsorption; prebiotic chemistry 1. Introduction Minerals can be very promising surfaces for studying biomolecule surface processes, which are of principal relevance in the origin of life and a source of chemical complexity [1,2].
    [Show full text]
  • Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 As Used in Cosmetics
    Safety Assessment of Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics Status: Draft Final Report for Panel Review Release Date: May 16, 2014 Panel Meeting Date: June 9-10, 2014 The 2014 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A Hill, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst and Bart Heldreth, Ph.D., Chemist. © Cosmetic Ingredient Review 1620 L STREET, N.W., SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ [email protected] Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Wilbur Johnson, Jr. Senior Scientific Analyst Date: May 16, 2014 Subject: Draft Final Report on Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 At the March 17-18, 2014 Expert Panel meeting, the Panel concluded that tripeptide-1, hexapeptide-12, their metal salts and fatty acyl derivatives, and palmitoyl tetrapeptide-7 are safe in the present practices of use and concentration and issued a tentative report. Comments and use concentration data received from the Council have been addressed/ incorporated. Included in this package for your review is the draft final report, the CIR report history, Literature search strategy, Ingredient Data profile, 2014 FDA VCRP data, Minutes from the March 2014 Panel Meeting, and comments (pcpc1pdf file) and use concentration data (data 1 file) received from the Council.
    [Show full text]
  • Kinetic Properties and Characterization of Purified Proteases from Pacific Whiting
    AN ABSTRACT OF THE THESIS OF JuWen Wu for the degree of Master of Science in Food Science and Technology presented on March 10. 1994 . Title: Kinetic Properties and Characterization of Purified Proteases from Pacific Whiting (Merluccius productus) . Abstract approved: ._ ■^^HaejWg An Kinetic properties of the two proteases, causing textural degradation of Pacific whiting (Merluccius productus) during heating, were compared and characterized with the synthetic substrate, Z-Phe-Arg-NMec. Pacific whiting P-I and P-II showed the highest specificity on Z-Phe-Arg-NMec, specific substrate for cathepsin L. The Km of 1 preactivated P-I and P-II were 62.98 and 76.02 (^M), and kcat, 2.38 and 1.34 (s" ) against Z-Phe-Arg-NMec at pH 7.0 and 30°C, respectively. Optimum pH stability for preactivated P-I and P-II is between 4.5 and 5.5. Both enzymes showed similar pH- induced preactivation profiles at 30oC. The maximal activity for both enzymes was obtained by preactivating the enzyme at a range of pH 5.5 to 7.5. The highest activation rate for both enzymes was determined at pH 7.5. At pH 5.5, the rate to reach the maximal activity was the slowest, but the activity was stable up to 1 hr. P-I and P-II shared similar temperature profiles at pH 5.5 and pH 7.0 studied. Optimum temperatures at pH 5.5 and 7.0 for both proteases on the same substrate were 550C. Significant thermal inactivation for both enzymes was shown at 750C.
    [Show full text]
  • Peptides and How They Work with Kristina Kannada, Hydropeptide Fine Lines and Wrinkles Are the #1 Concern for Skin Care Consumers Chronological Vs
    Peptides And How They Work with Kristina Kannada, Hydropeptide Fine lines and wrinkles are the #1 concern for skin care consumers Chronological vs. Photoaging Factors Involved in Skin Aging Proteolic activity: Increase in degradation of proteins by cellular enzymes Free radical damage: Increase in unpaired electrons that accelerate aging Growth factors: Decrease in signaling molecules and cellular processes DEJ: Decrease in skin cohesion What happens with aging? 1: Thinning of the skin 2: Collagen fragmentation 3: Dermal epidermal junction (DEJ) flattening 4: Wrinkle formation Collagen and Aging Collagen gives skin structural support. It is the most abundant form of protein in the ECM, and its decrease is a major factor in wrinkle formation. 29 types of collagen have been identified. They are divided into five families according to type of structure: Fibrillar (Type I, II, III, V, XI), Facit (Type IX, XII, XIV), Short Chain (Type VIII, X), Basement Member (Type IV), and Other (Type VI, VII, XIII). Important types of collagen in terms of skin aging: • I: Most abundant form. Gives strength to the dermis. • III: Second most abundant form. Gives elasticity to the dermis. • IV: Major component of basement membrane. Forms a "chicken-wire" mesh with laminins and proteoglycans that influence cell adhesion, migration and differentiation. • V: Regulates the diameter of Collagen I and III fibers. • VI: A major component of microfibrils. Increases cell strength. • VII: Provides stability and anchors the dermis to the DEJ. • XVII: A transmembrane protein that is a structural component of hemidesmosomes, improving adhesion of the keratinocytes to the underlying membrane. A good skin care regimen must support multiple skin proteins for the best results.
    [Show full text]
  • The Amyloid-Beta Forming Tripeptide Cleavage Mechanism of G-Secretase David M Bolduc*, Daniel R Montagna, Matthew C Seghers, Michael S Wolfe*, Dennis J Selkoe*
    RESEARCH ARTICLE The amyloid-beta forming tripeptide cleavage mechanism of g-secretase David M Bolduc*, Daniel R Montagna, Matthew C Seghers, Michael S Wolfe*, Dennis J Selkoe* Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States Abstract g-secretase is responsible for the proteolysis of amyloid precursor protein (APP) into short, aggregation-prone amyloid-beta (Ab) peptides, which are centrally implicated in the pathogenesis of Alzheimer’s disease (AD). Despite considerable interest in developing g-secretase targeting therapeutics for the treatment of AD, the precise mechanism by which g-secretase produces Ab has remained elusive. Herein, we demonstrate that g-secretase catalysis is driven by the stabilization of an enzyme-substrate scission complex via three distinct amino-acid-binding pockets in the enzyme’s active site, providing the mechanism by which g-secretase preferentially cleaves APP in three amino acid increments. Substrate occupancy of these three pockets occurs after initial substrate binding but precedes catalysis, suggesting a conformational change in substrate may be required for cleavage. We uncover and exploit substrate cleavage preferences dictated by these three pockets to investigate the mechanism by which familial Alzheimer’s disease mutations within APP increase the production of pathogenic Ab species. DOI: 10.7554/eLife.17578.001 *For correspondence: [email protected] (DMB); Introduction [email protected] Alzheimer’s disease (AD) is the most common form of dementia and currently the sixth leading cause (MSW); [email protected] of death in the United States, with no disease-modifying therapeutics available. A central and patho- (DJS) logical hallmark of AD is the deposition of amyloid-beta (Ab) plaques in the brain (Hardy and Sel- Competing interests: The koe, 2002).
    [Show full text]
  • A Peptide-Hormone-Inactivating Endopeptidase in Xenopus Laevis Skin Secretion
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 84-88, January 1992 Biochemistry A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion (metailoendopeptidase/neutral endopeptidase/thermolysin) KRISHNAMURTI DE MORAIS CARVALHO*, CARINE JOUDIOU, HAMADI BOUSSETTA, ANNE-MARIE LESENEY, AND PAUL COHEN Groupe de Neurobiochimie Cellulaire et Moldculaire de l'Universitd Pierre et Marie Curie, Unit6 de Recherche Associ6e 554 au Centre National de la Recherche Scientifique, % Boulevard Raspail, 75006 Paris, France Communicated by I. Robert Lehman, September 16, 1991 ABSTRACT An endopeptidase was isolated from Xenopus Indeed the Ser-Phe dipeptide, or a related motif such as laevis skin secretions. This enzyme, which has an apparent Phe-Phe, Ala-Phe, or His-Phe, is often present near the molecular mass of 100 kDa, performs a selective cleavage at the carboxyl terminus of substances from the bombesin and Xaa-Phe, Xaa-Leu, or Xaa-Ile bond (Xaa = Ser, Phe, Tyr, His, tachykinin families (1). Xaa-Phe, Xaa-Leu, or Xaa-Ile was or Gly) of a number of peptide hormones, including atrial also found frequently at a similar position in other peptide natriuretic factor, substance P, angiotensin H, bradykinin, hormone sequences of higher organisms, notably in atrial somatostatin, neuromedins B and C, and litorin. The peptidase natriuretic factor (ANF). exhibited optimal activity at pH 7.5 and aKm in the micromolar We have purified this enzyme 2029-fold and demonstrate range. No cleavage was produced in vasopressin, ocytocin, that it inactivates ANF by exclusive cleavage of the Ser25- minigastrin I, and [Leu5Jenkephalin, which include in their Phe26 bond and similarly inactivates a number of important sequence an Xaa-Phe, Xaa-Leu, or Xaa-Ile motif.
    [Show full text]
  • 18.4 Peptides 559
    18.4 Peptides 559 18.4Peptides AIMS: Tonome ond describethe bond thot linksomino ocids together.To drow completestructirol formulos for simple peptides.To controstthe biologicol functionsof some peptide hormones. A peptide is any combination of amino acids in which the alpha amino Focus group (-NH) of one acid is united with the alpha carboxylic group Amino acids are linked to form (-CO2H) of another through an amide bond. peptides. RO RO til ril H2N-C-C-OH + H-N-C-C-OH ------- I H HH Amino acid Amino acid RO RO til ttl H2N-C-C-N-C-C-OH + H2O ttt H HH Peptide The amide bonds formed in peptides always involve the alpha amino and alpha carboxylic acid groups and never those of side chains. More amino acids maybe added in the same fashion to form chains such as those in Figure l9.l. The amide bond between the carbonyl group of one amino acid and the nitrogen of the next amino acid in the peptide chain is called a peptide bond, or peptide link. Amino acids that haue been incorporated into peptides are called amino acid residues. As more amino acid residues are added, a backbone common to all peptide molecules is formed. The amino acid residue with a free amino group at one end of the chain is the N-termi- nal residue:the residue with a free carboxvlic acid at the other end of the chain is the C-terminal residue.The number of amino acid residuesin a peptide is often indicated by a set of preflxes for peptides of up to l0 C-terminal residue Figutel8.l Partsof a peptide-in this case,a tetrapeptide.The peptide bonds of the zigzagbackbone are shown in color.Note that the C-terminalis at the right and the N-terminqlis at the left.
    [Show full text]
  • Cosmetic Peptide Synthesis
    Cosmetic Peptide Synthesis Hair/Eyelash/Eyebrow Care Series Anti-Aging Prevent UV Damage Whitening Skin Renewal Slimming & Breast Enhancement Anti-Wrinkle Anti-allergic &Anti-Inflammatory Eye Care Cosmetic Peptides Bioactive Peptides have been widely used in cosmetics, which can be applied to anti-wrinkle, whitening, and skin regeneration areas. GenScript has more than 15 years of peptide synthesis experience and has provided high-quality peptides to over 10,000 customers worldwide. We are now offering cosmetic peptides synthesis service to fulfill your research needs in this area. Why choose GenScript? Skilled Technical Support Strict Quality Control Team of PhD Experts Batch-to-Batch Stability High Throughput Production Customizable Services to Meet Cost Effective and Fast Delivery Different Needs Categories Hair/Eyelash/Eyebrow Care Series Anti-Aging Prevent UV Damage Whitening Skin Renewal Slimming & Breast Enhancement Anti-Wrinkle Anti-allergic & Anti-Inflammatory Eye Care Hair/Eyelash/Eyebrow Care Series Product Activity Myristoyl Octapeptide-2 Promote hair growth Myristoyl Hexapeptide-16 Promote eyelash growth Myristoyl Tetrapeptide-12 Promote hair growth Myristoyl Pentapeptide-17 Promote eyelash and eyebrow growth Biotinoyl Tripeptide-1 Promote eyelash and eyebrow growth Acetyl Tetrapeptide-3 Promote eyelash and eyebrow growth Curcuminy1 Glutaryol Hexapeptide-24 Amide Promote eyelash and eyebrow growth Copper Tripeptide-1 Promote eyelash and eyebrow growth Copper Tripeptide-3 Promote eyelash and eyebrow growth Decapeptide-10 Promote
    [Show full text]